These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2416597)

  • 21. Investigation of toxin genes by polymerase chain reaction in Staphylococcus aureus strains isolated from bovine mastitis in Turkey.
    Karahan M; Açik MN; Cetinkaya B
    Foodborne Pathog Dis; 2009 Oct; 6(8):1029-35. PubMed ID: 19642915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets.
    Mohana R; Venugopal S
    Infect Disord Drug Targets; 2017; 17(2):130-142. PubMed ID: 28034364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Demonstration by electrosyneresis of 2 exfoliation serotypes produced by Staphylococcus aureus].
    Piémont Y; Monteil H
    Ann Microbiol (Paris); 1983; 134A(2):169-75. PubMed ID: 6870085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus.
    Redpath MB; Foster TJ; Bailey CJ
    FEMS Microbiol Lett; 1991 Jun; 65(2):151-5. PubMed ID: 1884990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidermolytic (exfoliative) toxins of Staphylococcus aureus.
    Bailey CJ; Lockhart BP; Redpath MB; Smith TP
    Med Microbiol Immunol; 1995 Aug; 184(2):53-61. PubMed ID: 7500911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution.
    Pearton DJ; Dale BA; Presland RB
    J Invest Dermatol; 2002 Sep; 119(3):661-9. PubMed ID: 12230510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediates in the conversion of prekeratin into keratin molecules in human epidermis.
    Katagata Y; Aso K
    FEBS Lett; 1984 Dec; 178(1):92-6. PubMed ID: 6209169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice.
    Shibl AM
    Chemotherapy; 1981; 27(3):224-7. PubMed ID: 7226975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus.
    de Azavedo J; Arbuthnott JP
    J Med Microbiol; 1981 Aug; 14(3):341-4. PubMed ID: 7265167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Filaggrin, an intermediate filament-associated protein: structural and functional implications from the sequence of a cDNA from rat.
    Haydock PV; Dale BA
    DNA Cell Biol; 1990 May; 9(4):251-61. PubMed ID: 1693512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of filaggrin in psoriasis].
    Fedi AM; Leoncini P; Farella V; Lotti T
    G Ital Dermatol Venereol; 1989 Apr; 124(4):141-5. PubMed ID: 2680915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic aspects of protein deimination in developing mouse epidermis.
    Akiyama K; Senshu T
    Exp Dermatol; 1999 Jun; 8(3):177-86. PubMed ID: 10389634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of epidermolytic toxin from Staphylococcus aureus to mouse epidermal tissue.
    Smith TP; John DA; Bailey CJ
    Histochem J; 1987 Mar; 19(3):137-49. PubMed ID: 3110115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staphylococcus aureus exfoliative toxins: how they cause disease.
    Plano LR
    J Invest Dermatol; 2004 May; 122(5):1070-7. PubMed ID: 15140205
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidermal toxin production by Staphylococcus aureus strains from patients with toxic shock syndrome.
    Kapral FA
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):972-4. PubMed ID: 7091978
    [No Abstract]   [Full Text] [Related]  

  • 36. Normal human epidermal keratinocytes express in vitro specific molecular forms of (pro)filaggrin recognized by rheumatoid arthritis-associated antifilaggrin autoantibodies.
    Girbal-Neuhauser E; Montézin M; Croute F; Sebbag M; Simon M; Durieux JJ; Serre G
    Mol Med; 1997 Feb; 3(2):145-56. PubMed ID: 9085257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The search for strains of Staphylococcus aureus producing exfoliative toxin].
    Brevis P; Padilla C; Herrera R; Goset C
    Rev Latinoam Microbiol; 1988; 30(1):1-4. PubMed ID: 3140339
    [No Abstract]   [Full Text] [Related]  

  • 38. The epidermolytic toxins are serine proteases.
    Dancer SJ; Garratt R; Saldanha J; Jhoti H; Evans R
    FEBS Lett; 1990 Jul; 268(1):129-32. PubMed ID: 2384148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental expression of human epidermal keratins and filaggrin.
    Dale BA; Holbrook KA
    Curr Top Dev Biol; 1987; 22():127-51. PubMed ID: 2443308
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
    Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM
    Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.